Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
Status:
Active, not recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The aim ot the study is to investigate the efficacy and safety of two new intensified
chemotherapy regimens (gemcitabine (Gem)/nab- paclitaxel (PAC), FOLFIRINOX) as neoadjuvant
chemotherapy protocol in locally advanced, non-metastatic pancreatic cancer (LAPC) and
consecutive conversion of the tumor to resectability.